vs
Laird Superfood, Inc.（LSF）与TriSalus Life Sciences, Inc.（TLSI）财务数据对比。点击上方公司名可切换其他公司
Laird Superfood, Inc.的季度营收约是TriSalus Life Sciences, Inc.的1.0倍（$13.3M vs $13.2M），Laird Superfood, Inc.净利率更高（-13.2% vs -73.9%，领先60.7%），TriSalus Life Sciences, Inc.同比增速更快（59.8% vs 15.0%），过去两年TriSalus Life Sciences, Inc.的营收复合增速更高（43.0% vs 16.1%）
Laird Superfood是一家主营植物基功能性超级食品的企业，产品涵盖精品咖啡奶精、补水混合饮品、营养补充剂、植物能量零食等，面向健康意识较强的消费群体，主要在北美市场通过电商及线下零售渠道销售，主打可持续采购的清洁配方。
TriSalus生命科学公司是一家临床阶段生物技术企业，专注于免疫肿瘤学与介入肿瘤学领域，研发专有的靶向给药技术，用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果，主要在北美市场开展临床合作及业务运营。
LSF vs TLSI — 直观对比
营收规模更大
LSF
是对方的1.0倍
$13.2M
营收增速更快
TLSI
高出44.8%
15.0%
净利率更高
LSF
高出60.7%
-73.9%
两年增速更快
TLSI
近两年复合增速
16.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.3M | $13.2M |
| 净利润 | $-1.8M | $-9.8M |
| 毛利率 | 34.1% | 86.7% |
| 营业利润率 | -13.5% | -24.8% |
| 净利率 | -13.2% | -73.9% |
| 营收同比 | 15.0% | 59.8% |
| 净利润同比 | -341.4% | 3.5% |
| 每股收益（稀释后） | — | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LSFTLSI
| Q4 25 | $13.3M | $13.2M | ||
| Q3 25 | $12.9M | $11.6M | ||
| Q2 25 | $12.0M | $11.2M | ||
| Q1 25 | $11.7M | $9.2M | ||
| Q4 24 | $11.6M | $8.3M | ||
| Q3 24 | $11.8M | $7.3M | ||
| Q2 24 | $10.0M | $7.4M | ||
| Q1 24 | $9.9M | $6.5M |
净利润LSFTLSI
| Q4 25 | $-1.8M | $-9.8M | ||
| Q3 25 | $-975.1K | $-10.8M | ||
| Q2 25 | $-362.2K | $-8.3M | ||
| Q1 25 | $-156.2K | $-10.4M | ||
| Q4 24 | $-398.4K | $-10.1M | ||
| Q3 24 | $-166.1K | $-2.4M | ||
| Q2 24 | $-239.1K | $-4.3M | ||
| Q1 24 | $-1.0M | $-13.2M |
毛利率LSFTLSI
| Q4 25 | 34.1% | 86.7% | ||
| Q3 25 | 36.5% | 83.5% | ||
| Q2 25 | 39.9% | 83.9% | ||
| Q1 25 | 41.9% | 83.7% | ||
| Q4 24 | 38.6% | 85.3% | ||
| Q3 24 | 43.0% | 86.3% | ||
| Q2 24 | 41.8% | 87.6% | ||
| Q1 24 | 40.0% | 85.0% |
营业利润率LSFTLSI
| Q4 25 | -13.5% | -24.8% | ||
| Q3 25 | -7.7% | -77.9% | ||
| Q2 25 | -3.3% | -65.4% | ||
| Q1 25 | -1.9% | -79.9% | ||
| Q4 24 | -4.1% | -91.8% | ||
| Q3 24 | -2.3% | -118.9% | ||
| Q2 24 | -3.4% | -111.0% | ||
| Q1 24 | -11.0% | -180.8% |
净利率LSFTLSI
| Q4 25 | -13.2% | -73.9% | ||
| Q3 25 | -7.6% | -93.5% | ||
| Q2 25 | -3.0% | -73.9% | ||
| Q1 25 | -1.3% | -113.2% | ||
| Q4 24 | -3.4% | -122.4% | ||
| Q3 24 | -1.4% | -32.6% | ||
| Q2 24 | -2.4% | -58.8% | ||
| Q1 24 | -10.3% | -204.5% |
每股收益（稀释后）LSFTLSI
| Q4 25 | — | $-0.22 | ||
| Q3 25 | — | $-0.96 | ||
| Q2 25 | — | $-0.27 | ||
| Q1 25 | — | $-0.39 | ||
| Q4 24 | — | $-0.38 | ||
| Q3 24 | — | $-0.12 | ||
| Q2 24 | — | $-0.21 | ||
| Q1 24 | — | $-0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.1M | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $11.5M | $-33.9M |
| 总资产 | $19.2M | $35.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LSFTLSI
| Q4 25 | $5.1M | $20.4M | ||
| Q3 25 | $5.1M | $22.7M | ||
| Q2 25 | $3.9M | $26.5M | ||
| Q1 25 | $7.0M | $13.0M | ||
| Q4 24 | $8.3M | $8.5M | ||
| Q3 24 | $7.9M | $11.3M | ||
| Q2 24 | $7.6M | $16.5M | ||
| Q1 24 | $7.1M | $4.0M |
股东权益LSFTLSI
| Q4 25 | $11.5M | $-33.9M | ||
| Q3 25 | $12.8M | $-26.7M | ||
| Q2 25 | $13.4M | $-19.4M | ||
| Q1 25 | $13.3M | $-34.4M | ||
| Q4 24 | $13.2M | $-25.9M | ||
| Q3 24 | $13.1M | $-20.4M | ||
| Q2 24 | $12.6M | $-25.3M | ||
| Q1 24 | $12.7M | $-36.0M |
总资产LSFTLSI
| Q4 25 | $19.2M | $35.3M | ||
| Q3 25 | $18.9M | $36.5M | ||
| Q2 25 | $20.4M | $41.3M | ||
| Q1 25 | $21.5M | $28.6M | ||
| Q4 24 | $19.3M | $24.0M | ||
| Q3 24 | $18.8M | $27.5M | ||
| Q2 24 | $18.0M | $32.4M | ||
| Q1 24 | $17.6M | $17.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $68.4K | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-2.5M |
| 自由现金流率自由现金流/营收 | — | -19.1% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-19.1M |
8季度趋势，按日历期对齐
经营现金流LSFTLSI
| Q4 25 | $68.4K | $-2.5M | ||
| Q3 25 | $1.2M | $-3.7M | ||
| Q2 25 | $-2.8M | $-7.3M | ||
| Q1 25 | $-1.3M | $-4.5M | ||
| Q4 24 | $339.2K | $-5.7M | ||
| Q3 24 | $305.8K | $-10.8M | ||
| Q2 24 | $642.7K | $-13.4M | ||
| Q1 24 | $-422.3K | $-10.9M |
自由现金流LSFTLSI
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | — | $-7.4M | ||
| Q1 25 | — | $-5.3M | ||
| Q4 24 | — | $-5.8M | ||
| Q3 24 | — | $-11.0M | ||
| Q2 24 | — | $-13.5M | ||
| Q1 24 | — | $-10.9M |
自由现金流率LSFTLSI
| Q4 25 | — | -19.1% | ||
| Q3 25 | — | -33.9% | ||
| Q2 25 | — | -66.1% | ||
| Q1 25 | — | -57.3% | ||
| Q4 24 | — | -69.7% | ||
| Q3 24 | — | -149.9% | ||
| Q2 24 | — | -183.1% | ||
| Q1 24 | — | -169.3% |
资本支出强度LSFTLSI
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 1.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
TLSI
暂无分部数据
